Optain pairs Resolve™, our FDA-cleared robotic camera, with rapid teleophthalmology grading. So simple, it becomes part of every visit. No dilation required, no specialist referral, no patient drop-off. Backed by Insight.
About the role
Optain is at an inflection point. We have FDA clearance, roughly 50,000 patients screened annually, and exponential growth in our enterprise segment. The operational infrastructure to support that growth is being built from zero right now, and this role owns that build.
What they're looking for
- 3-5 years in business or operations roles, with hands-on ownership of hardware logistics or commercial contract management (both is a plus)
- Startup experience strongly preferred -- you have worked in a Series A or B environment and are comfortable operating without a defined playbook
- Prior experience in management consulting or investment banking is a plus -- we value the analytical rigor and work product standards that come with it
- Experience in a regulated industry is a strong plus, medical device, IVD, or health tech with a hardware component is ideal
- A systems thinker who leaves every process easier to run than they found it
- Hands-on with AI tooling, including building or automating real workflows
More about this role
Optain is a revolutionary healthcare company that uses groundbreaking software and hardware technology to rethink care. We use the eye as a window to the body to improve the way we detect and manage eye and systemic conditions. Optain is committed to expanding and improving care through the introduction of AI and machine learning technology in frontline care settings at an accessible price. This not only promotes greater access to care, but promises to reduce the strains of overburdened healthcare systems.
Originally founded in Australia in 2019, Optain seeks to commercialize the inventions of Professor Mingguang He, a preeminent clinician-scientist and scholar in the field of ophthalmology. Optain has achieved regulatory approval and commercial adoption of its product suite in global markets, including Australia, Europe, and more.
In 2025, Optain received US FDA clearance for its Resolve retinal camera. Optain also recently closed a Series A funding round led by Insight Partners with participation from seven leading U.S. health system investors, including Memorial Hermann Health System, Northwell Health, Novant Health, The Ohio State University Wexner Medical Center, and UPMC....
Browse similar: Startup jobs · Remote jobs